Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

What this doesn’t do is create the stable regulatory environment which is needed for companies to invest the hundreds of millions of dollars it costs to show that other new vaccines worth. Stuff like the Epstein-Barr virus vaccine will likely never become available, and we’ll never know if it’s possible to prevent Parkinson’s with a vaccine.

  • crusa187@lemmy.ml
    link
    fedilink
    arrow-up
    1
    ·
    2 hours ago

    Well corruption is a safe assumption with this admin, I’m not really knowledgeable on Moderna business dealings these days but could definitely see it playing out this way instead. Thanks for the insight.